Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brain.
Adeno-associated virus (AAV) mediated gene expression is a powerful tool for gene therapy and preclinical studies. A comprehensive analysis of CNS cell type tropism, expression levels and biodistribution of different capsid serotypes has not yet been undertaken in neonatal rodents. Our previous stud...
Main Authors: | Paramita Chakrabarty, Awilda Rosario, Pedro Cruz, Zoe Siemienski, Carolina Ceballos-Diaz, Keith Crosby, Karen Jansen, David R Borchelt, Ji-Yoen Kim, Joanna L Jankowsky, Todd E Golde, Yona Levites |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3692458?pdf=render |
Similar Items
-
Rationally Engineered AAV Capsids Improve Transduction and Volumetric Spread in the CNS
by: Nicholas M. Kanaan, et al.
Published: (2017-09-01) -
An AAV capsid increases transduction of striatum and a ChAT promoter allows selective cholinergic neuron transduction
by: Miguel C. Santoscoy, et al.
Published: (2023-06-01) -
Reciprocal mutations of lung-tropic AAV capsids lead to improved transduction properties
by: Ashley L. Cooney, et al.
Published: (2023-11-01) -
AAV-S: A versatile capsid variant for transduction of mouse and primate inner ear
by: Maryna V. Ivanchenko, et al.
Published: (2021-06-01) -
Comparison of the Transduction Capacity of AAV5 and AAV PHP.eB Serotypes in Hippocampus Astroglia
by: Anastasia Borodinova, et al.
Published: (2023-11-01)